BioCardia (BCDA) Current Deferred Revenue (2015 - 2023)
BioCardia (BCDA) posted Current Deferred Revenue of $333,000 for Q2 2023, down 2.1% from the prior quarter.
Powered by 
Analysis
BioCardia (BCDA) Current Deferred Revenue (2015 - 2023) Analysis & Trends
At the end of FY2022, BioCardia's Current Deferred Revenue came in at $341,000, down 59.7% from FY2021.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 15.3% (FY2017 to FY2022).
- In prior years, BioCardia's Current Deferred Revenue was $847,000 in FY2021 (+24.0%), $683,000 in FY2020 (+569.6%), $102,000 in FY2019 (-8.9%) and $112,000 in FY2018 (-32.9%).
- The Q2 2023 figure stands as the lowest quarterly Current Deferred Revenue since Q3 2020.
- On a year-over-year basis, Current Deferred Revenue increased in two of the last six quarters, with growth averaging 117.9%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2021, with growth of 884.4%; the weakest was Q3 2020, with a decline of 64.3%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $340,000 (Q1 2023), $341,000 (Q4 2022) and $378,000 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | BioCardia | 12.46 Mn | -407,934.31 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 333,000.00 |
| Mar 31, 2023 | 340,000.00 |
| Dec 31, 2022 | 341,000.00 |
| Sep 30, 2022 | 378,000.00 |
| Mar 31, 2022 | 948,000.00 |
| Dec 31, 2021 | 847,000.00 |
| Sep 30, 2021 | 886,000.00 |
| Jun 30, 2021 | 1.42 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 683,000.00 |
| Sep 30, 2020 | 90,000.00 |
| Jun 30, 2020 | 104,000.00 |
| Mar 31, 2020 | 104,000.00 |
| Dec 31, 2019 | 102,000.00 |
| Sep 30, 2019 | 252,000.00 |
| Jun 30, 2019 | 104,000.00 |
| Mar 31, 2019 | 118,000.00 |
| Dec 31, 2018 | 112,000.00 |
| Mar 31, 2018 | 60,000.00 |
| Dec 31, 2017 | 167,000.00 |
API Access
BioCardia Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BCDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();